Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
Clinical trial NCT05167409 · TERMINATED
Trial details
- NCT number
- NCT05167409
- Sponsor
- University of Colorado, Denver
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-28
- Primary completion
- 2024-10-30
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.